» Articles » PMID: 33438770

Fibronectin Assembly Regulates Lumen Formation in Breast Acini

Overview
Journal J Cell Biochem
Date 2021 Jan 13
PMID 33438770
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Fibronectin (FN) is an extracellular matrix (ECM) glycoprotein that self-assembles into FN fibrils, forming a FN matrix contributing to the stiffness of the ECM. Stromal FN stiffness in cancer has been shown to impact epithelial functions such as migration, cancer metastasis, and epithelial-to-mesenchymal transition. The role of the FN matrix of epithelial cells in driving such processes remains less well understood and is the focus of this study. Hypoxia, defined by low oxygen tension (<5%) is one of the hallmarks of tumor microenvironments impacting fibril reorganization in stromal and epithelial cells. Here, using the MCF10 breast epithelial progression series of cell lines encompassing normal, preinvasive, and invasive states, we show that FN fibril formation decreases during hypoxia, coinciding with a decrease in migratory potential of these cells. Conversely, we find that FN fibril disruption during three-dimensional acinar growth of normal breast cells resulted in acinar luminal filling. Our data also demonstrates that the luminal filling upon fibril disruption in untransformed MCF10A cells results in a loss of apicobasal polarity, characteristic of pre-invasive and invasive breast cell lines MCF10AT and MCF10 DCIS.com. Overall this is the first study that relates fibril-mediated changes in epithelial cells as critical players in lumen clearing of breast acini and maintenance of the untransformed growth characteristic.

Citing Articles

Three-Dimensional Models: Biomimetic Tools That Recapitulate Breast Tissue Architecture and Microenvironment to Study Ductal Carcinoma In Situ Transition to Invasive Ductal Breast Cancer.

Shah S, Osuala K, Brock E, Ji K, Sloane B, Mattingly R Cells. 2025; 14(3).

PMID: 39937011 PMC: 11817749. DOI: 10.3390/cells14030220.


The Microenvironment in DCIS and Its Role in Disease Progression.

Roozitalab M, Prekete N, Allen M, Grose R, Jones J Adv Exp Med Biol. 2025; 1464():211-235.

PMID: 39821028 DOI: 10.1007/978-3-031-70875-6_12.


Differential regulation of fibronectin expression and fibrillogenesis by autocrine TGF-β1 signaling in malignant and benign mammary epithelial cells.

Sofroniou M, Lemmon C Int J Biochem Cell Biol. 2023; 165:106478.

PMID: 37866655 PMC: 10775780. DOI: 10.1016/j.biocel.2023.106478.


A TGFβ-ECM-integrin signaling axis drives structural reconfiguration of the bile duct to promote polycystic liver disease.

Waddell S, Yao Y, Olaizola P, Walker A, Jarman E, Gournopanos K Sci Transl Med. 2023; 15(713):eabq5930.

PMID: 37703354 PMC: 7615241. DOI: 10.1126/scitranslmed.abq5930.


JNJ-64619178 radiosensitizes and suppresses fractionated ionizing radiation-induced neuroendocrine differentiation (NED) in prostate cancer.

Pawar J, Al-Amin M, Hu C Front Oncol. 2023; 13:1126482.

PMID: 36959798 PMC: 10028149. DOI: 10.3389/fonc.2023.1126482.


References
1.
Shinde A, Libring S, Alpsoy A, Abdullah A, Schaber J, Solorio L . Autocrine Fibronectin Inhibits Breast Cancer Metastasis. Mol Cancer Res. 2018; 16(10):1579-1589. PMC: 6511995. DOI: 10.1158/1541-7786.MCR-18-0151. View

2.
Pasqualini R, Bourdoulous S, Koivunen E, Woods Jr V, Ruoslahti E . A polymeric form of fibronectin has antimetastatic effects against multiple tumor types. Nat Med. 1996; 2(11):1197-203. DOI: 10.1038/nm1196-1197. View

3.
Gligorijevic B, Bergman A, Condeelis J . Multiparametric classification links tumor microenvironments with tumor cell phenotype. PLoS Biol. 2014; 12(11):e1001995. PMC: 4227649. DOI: 10.1371/journal.pbio.1001995. View

4.
Balanis N, Wendt M, Schiemann B, Wang Z, Schiemann W, Carlin C . Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway. J Biol Chem. 2013; 288(25):17954-67. PMC: 3689941. DOI: 10.1074/jbc.M113.475277. View

5.
Weaver V, Petersen O, Wang F, Larabell C, Briand P, Damsky C . Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol. 1997; 137(1):231-45. PMC: 2139858. DOI: 10.1083/jcb.137.1.231. View